16 results
8-K
EX-1.2
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
(the “FCPA”), or any other applicable anti-bribery or anti-corruption laws (the “Anti-Corruption Laws”) including, without limitation, making use … of the Anti-Corruption Laws and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance with the Anti
8-K
EX-1.1
GOSS
Gossamer Bio Inc
21 May 20
Gossamer Bio Announces Proposed Concurrent Public Offerings of Common Stock and Convertible Senior Notes due 2027
4:06pm
and regulations thereunder (the “FCPA”), or any other applicable anti-bribery or anti-corruption laws (the “Anti-Corruption Laws”) including, without limitation … , in contravention of the Anti-Corruption Laws and the Company and, to the knowledge of the Company, its affiliates have conducted their businesses in compliance
8-K
EX-10.1
730w 9057um
3 May 19
Gossamer Bio Secures Debt Facility for Up to $150 Million
4:00pm
10-K
6k60 ywxku
22 Mar 19
Annual report
4:45pm
424B4
23o6rg3hxwjr6da
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-1.1
nq6leclup7bnm
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
0eq9antp
23 Jan 19
IPO registration (amended)
4:39pm
S-1
xrofb6jj0m3fsqod
21 Dec 18
IPO registration
4:39pm
DRS/A
61y4nm inhm8cv
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
72i czfhrc9ak0mqmw
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next